Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Grant or award SVP, Chief Operating Officer acquired 11,648 shares (grant or award)
  2. 4 Grant or award CEO and President acquired 39,520 shares (grant or award)
  3. 4 Grant or award SVP, Chief Medical Officer acquired 10,400 shares (grant or award)
  4. 4 Open-market sale CEO and President sold 49,990 shares at $3.40 ($169,771)
  5. 4 Open-market sale CCO sold 6,749 shares at $3.40 ($22,920)
  6. 4 Open-market sale SVP, Chief Legal Officer sold 14,285 shares at $3.40 ($48,513)
  7. 4 Open-market sale SVP, Chief Operating Officer sold 14,547 shares at $3.40 ($49,403)
  8. 4 Open-market sale SVP, Chief Medical Officer sold 7,558 shares at $3.40 ($25,668)
  9. 4 Grant or award SVP, Chief Accounting Officer acquired 26,000 shares (grant or award)
  10. 4 Grant or award SVP, CFO and Treasurer acquired 70,000 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale Director sold 4,567 shares at $12.10 ($55,261)
  17. 4 Open-market sale Director sold 4,567 shares at $12.08 ($55,169)
  18. 4 Open-market sale Director sold 4,567 shares at $12.05 ($55,032)
  19. 4 Grant or award Director acquired 13,700 shares (grant or award)
  20. 4 Grant or award Director acquired 13,700 shares (grant or award)

Page 8 of 19 · 378 filings